Patent Expiration definition

Patent Expiration is defined in Section 3.4.
View Source
Patent Expiration means, with respect to a particular patent, that patent’s expiration, abandonment, cancellation, award to a party other than Licensor in an interference proceeding, or a final declaration of invalidity or unenforceability by a court or other authority of competent jurisdiction (including final rejection in a re-examination or re-issue proceeding) from which no further appeal has or can be taken, or being rendered unenforceable for any other reason.
View Source
Patent Expiration means the earlier of (i) the expiration of the DATE" last to expire of the patents covering the Product (including Patents, if applicable) or (ii) the date that all remaining unexpired patent(s) covering the Product (including Patents, if applicable) have been invalidated in a decision by a court of competent jurisdiction for which no appeal has been sought.
View Source

Examples of Patent Expiration in a sentence

  • The Notice of Patent Expiration shall state whether the Event results in a Special Use Product and describe any product-specific stewardship programs in place for that Special Use Product.

  • The Administrator shall post on the website any information or notice of interest to the agricultural community relating to the GEMAA, including any Notice of Discontinuation of Regulatory Responsibilities, notice of Last Sale, or Notice of Patent Expiration received by the Administrator.

  • If a Covered Event is already within three (3) years of Patent Expiration at the time the PRP Holder for such Covered Event signs this Agreement, then Notice of Patent Expiration will be given within sixty (60) days after such PRP Holder executes this Agreement or sixty (60) days after this Agreement becomes effective, whichever is later.

  • For the avoidance of doubt, should the Product Patent Expiration Date occur less than ten (10) years from the Date of First Commercial Sale for a particular Licensed Patent Product, then such product shall thereafter be a Licensed Know-How Product, and NYU shall receive royalties at the Licensed Know-How Product royalty rate for the remainder of such ten (10) year term.

  • If the PRP ▇▇▇▇▇▇ is not the patent holder for all patents that read on the Covered Event, the PRP Holder shall use reasonable best efforts to ascertain the date of Patent Expiration and if the PRP Holder cannot do so, will provide a good faith estimate of that date.

  • The license granted in this Agreement shall be Exclusive in the Field of Use until the later of (i) the Patent Expiration Date or (ii) the date described in Section 8.1(c)(ii) (the "LICENSE TERM"), unless terminated earlier as provided herein, and commencing as of the Effective Date of this Agreement.

  • The PRP Holder will notify the Administrator of Patent Expiration at least three (3) years prior to Patent Expiration of the last United States patent having claims that read on the Covered Event; provided that, if Patent Expiration is the result of either Paragraph 2.k) (2), (3) or (4), then Notice of Patent Expiration will be given as soon as practicable after such expiration.

  • After the Patent Expiration Date, the license granted in Article 3 shall become fully paid-up, royalty-free, perpetual and irrevocable in such country, subject to Section 7.10.

  • This Agreement shall begin on the Effective Date and shall end upon the expiration of the last to expire of the CORVAS Patent Rights (the "Patent Expiration Date"), unless terminated earlier in accordance with the terms of this Agreement (the "Term").

  • In the alternative, upon Patent Expiration and the approval of a generic version of the Product in each country, Lung Rx may elect not to terminate the Agreement as to such country in which case the royalty rates set forth in subsections (a) — (e) above shall be reduced by fifty percent (50%) with respect to Net Sales of Products.